Nan Fung Group Holdings
Latest statistics and disclosures from Nan Fung Group Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Karuna Therapeutics Ord, ILMN, HRMY, Seagen, OCS, and represent 67.43% of Nan Fung Group Holdings's stock portfolio.
- Added to shares of these 5 stocks: ALPN, GERN, ATHA, KALV, CABA.
- Started 1 new stock position in ALPN.
- Reduced shares in these 8 stocks: Iveric Bio, Chinook Therapeutics, OCS, GTLB, Reata Pharmaceuticals Inc Cl A, MRUS, MDGL, XENE.
- Sold out of its positions in Chinook Therapeutics, GTLB, Iveric Bio, MDGL, Reata Pharmaceuticals Inc Cl A.
- Nan Fung Group Holdings was a net seller of stock by $-7.2M.
- Nan Fung Group Holdings has $124M in assets under management (AUM), dropping by -21.08%.
- Central Index Key (CIK): 0001782539
Tip: Access up to 7 years of quarterly data
Positions held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 39 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 30.9 | $38M | 226k | 169.09 |
|
|
| Illumina (ILMN) | 13.3 | $16M | 119k | 137.28 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 9.8 | $12M | 369k | 32.77 |
|
|
| Seagen | 8.1 | $10M | 47k | 212.15 |
|
|
| Oculis Holding Ordinary Shares (OCS) | 5.4 | $6.7M | -6% | 607k | 11.00 |
|
| Somalogic Class A Com | 3.3 | $4.1M | 1.7M | 2.39 |
|
|
| Exscientia Ads (EXAI) | 3.1 | $3.9M | 860k | 4.52 |
|
|
| Xenon Pharmaceuticals (XENE) | 3.0 | $3.6M | -6% | 107k | 34.16 |
|
| Merus N V (MRUS) | 2.6 | $3.2M | -9% | 137k | 23.58 |
|
| Replimune Group (REPL) | 2.6 | $3.2M | 185k | 17.11 |
|
|
| Kalvista Pharmaceuticals (KALV) | 1.8 | $2.3M | +14% | 235k | 9.63 |
|
| Beigene Sponsored Adr (BGNE) | 1.8 | $2.2M | 12k | 179.87 |
|
|
| Alpine Immune Sciences (ALPN) | 1.7 | $2.1M | NEW | 182k | 11.45 |
|
| Incyte Corporation (INCY) | 1.5 | $1.8M | 32k | 57.77 |
|
|
| Geron Corporation (GERN) | 1.3 | $1.6M | +94% | 754k | 2.12 |
|
| Exelixis (EXEL) | 1.1 | $1.4M | 64k | 21.85 |
|
|
| Bolt Biotherapeutics (BOLT) | 1.0 | $1.2M | 1.2M | 1.04 |
|
|
| Pacific Biosciences of California (PACB) | 0.9 | $1.1M | 137k | 8.35 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.9 | $1.1M | 494k | 2.17 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 0.7 | $919k | 40k | 22.93 |
|
|
| Entrada Therapeutics (TRDA) | 0.6 | $776k | 49k | 15.80 |
|
|
| Cabaletta Bio (CABA) | 0.6 | $718k | +14% | 47k | 15.22 |
|
| Argenx Se Sponsored Adr (ARGX) | 0.6 | $703k | 1.4k | 491.63 |
|
|
| Aerovate Therapeutics (AVTE) | 0.5 | $651k | 48k | 13.57 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $625k | 30k | 20.84 |
|
|
| Biomea Fusion (BMEA) | 0.4 | $550k | 40k | 13.76 |
|
|
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.4 | $505k | 371k | 1.36 |
|
|
| Athira Pharma (ATHA) | 0.3 | $364k | +1429% | 180k | 2.02 |
|
| Eargo Com New | 0.3 | $321k | 148k | 2.17 |
|
|
| BioMarin Pharmaceutical (BMRN) | 0.3 | $320k | 3.6k | 88.48 |
|
|
| Akero Therapeutics (AKRO) | 0.2 | $224k | 4.4k | 50.58 |
|
|
| Alx Oncology Hldgs (ALXO) | 0.2 | $201k | 42k | 4.80 |
|
|
| Affimed Therapeutics B V | 0.1 | $178k | 373k | 0.48 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $126k | 18k | 7.08 |
|
|
| Galera Therapeutics (GRTX) | 0.1 | $107k | 613k | 0.18 |
|
|
| Abcellera Biologics (ABCL) | 0.0 | $58k | 13k | 4.60 |
|
|
| Fibrogen (FGEN) | 0.0 | $54k | 62k | 0.86 |
|
|
| Kodiak Sciences (KOD) | 0.0 | $35k | 20k | 1.80 |
|
|
| Cerus Corporation (CERS) | 0.0 | $23k | 14k | 1.62 |
|
Past Filings by Nan Fung Group Holdings
SEC 13F filings are viewable for Nan Fung Group Holdings going back to 2021
- Nan Fung Group Holdings 2023 Q3 filed Nov. 13, 2023
- Nan Fung Group Holdings 2023 Q2 filed Aug. 11, 2023
- Nan Fung Group Holdings 2023 Q1 filed May 12, 2023
- Nan Fung Group Holdings 2022 Q4 filed Feb. 13, 2023
- Nan Fung Group Holdings 2022 Q3 filed Nov. 10, 2022
- Nan Fung Group Holdings 2022 Q2 filed Aug. 12, 2022
- Nan Fung Group Holdings 2022 Q1 filed May 13, 2022
- Nan Fung Group Holdings 2021 Q4 filed Feb. 14, 2022
- Nan Fung Group Holdings 2021 Q3 filed Nov. 15, 2021
- Nan Fung Group Holdings 2021 Q2 filed Sept. 22, 2021